News

Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.

Atherosclerosis, characterized by the buildup of plaque inside human arteries, is one of the leading causes of cardiovascular diseases. The disease is brought on by a complex interplay between lipids, inflammatory cells, and the ECM. Arterial blood flow is restricted as plaques form, which can rupture to cause blockage. Arterial blockage, or occlusion, is...

Discover how collagen hybridizing peptides (CHPs) outperform Masson's trichrome in detecting collagen in idiopathic pulmonary fibrosis (IPF) tissues.

Collagen Hybridizing Peptides (CHPs) revolutionize liver fibrosis detection by halving biopsy analysis time. Explore detailed insights into collagen remodeling and deposition, which is directly linked to fibrotic activity.